YS-201  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:1mg in glass bottle
产品描述:基本信息 产品编号: Y10040 产品名称: YS-201 CAS: 108852-42-2   储存条件 粉末 -20℃ 四年     分子式: C24H31N3O6 溶于液体 -80℃ 6个月 分子量: 457.52 -20℃ 1个月 化学名:  3,5-Pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,3-ethyl 5-[2-(1-piperidinyl)ethyl] ester Solubility (25°C):   体外:   DMSO   Ethanol   Water   体内(现配现用):   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   生物活性 产品描述 二氢吡啶类钙通道(calciumchannel)拮抗剂,有潜力用于心绞痛和高血压的研究。 靶点 Calcium Channel 体内研究 YS-201 (Diperdipine) markedly reduces systemic vascular resistance and improves stroke index and left ventricular ejection fraction.Mean pulmonary artery and wedge pressures are slightly increased as a possible consequence of enhanced venous return,whereas right atrial and left ventricular end-diastolic pressures are not significantly changed.Nevertheless,an increase in preload is clearly indicated by an augmented left ventricular end-diastolic volume index after administration of diperdipine.After intravenous and oral doses,absolute bioavailability is calculated to be 18.7%.Biliaryexcretion accounts for about 0.1% of the total clearance of diperdipine and does not contribute to the overall elimination of the drug.After intraportal administration,the bioavailable fraction of diperdipine is increasing up to 44.3% suggesting a prehepatic site of loss of the drug.The single application of diperdipine to mice and rats by gavage causes intolerance reactions starting at the lowest tested dose level of 200 mg/kg b.w.p.o.(mice) and at 250mg/kg b.w.p.o.(rats).In the rat,toxic effects occur from 15mg diperdipine/kg b.w./day p.o. onwards.
保存条件:-20℃